BERWYN, Pa.–(BUSINESS WIRE)–Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder,...
BERWYN, Pa.–(BUSINESS WIRE)–Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive product candidates for ... Read More
BERWYN, Pa.–(BUSINESS WIRE)–Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive product candidates for ... Read More
Recent research into CBD suggests that the cannabinoid can be used to reduce Covid rates. Before I’m “fact checked” by “keepers of truth”, I will reiterate that as of now there has been no clinical human trials and therefore the assumption that CBD may reduce Covid Rates is still volatile. In other words, a clinical trial could reveal different outcomes.
After two years, everyone has grown tired – dare we say we’re stressed. But new research does not recommend we sit back and smoke a joint, or even consume cannabis just yet. Fortunately, though, cannabis formulations consumed orally did reduce coronavirus replication in a lab. Cannabidiol (CBD) regulates the stress response which reduces viral replication […]